Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

Bosch and colleagues searched MEDLINE for studies published in English between 1966 and 2007 that evaluated the available treatments for antineutrophil cytoplasmic antibody (ANCA)-associated ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

Reducing glucocorticoid use in the treatment of giant cell arteritis ... Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal ...